WallStreetZenWallStreetZen

NASDAQ: IBRX
Immunitybio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for IBRX

Based on 1 analyst offering 12 month price targets for Immunitybio Inc.
Min Forecast
$5.00-8.93%
Avg Forecast
$5.00-8.93%
Max Forecast
$5.00-8.93%

Should I buy or sell IBRX stock?

Based on 1 analyst offering ratings for Immunitybio Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IBRX stock forecasts and price targets.

IBRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-25

1 of 1

Forecast return on equity

Is IBRX forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is IBRX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

IBRX revenue forecast

What is IBRX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$9.7M+1,456.27%
Avg 2 year Forecast
$84.7M+13,514.15%
Avg 3 year Forecast
$197.6M+31,665.27%
IBRX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IBRX revenue growth forecast

How is IBRX forecast to perform vs Biotechnology companies and vs the US market?
Company
574.96%
Industry
37.57%
Market
10.16%
IBRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IBRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IBRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IBRX$5.49$5.00-8.93%Hold
RARE$45.11$87.70+94.41%Strong Buy
INSM$25.27$45.86+81.47%Strong Buy
AXSM$73.08$126.80+73.51%Strong Buy
IOVA$11.86$25.50+115.01%Strong Buy
View Top Biotech Stocks

Immunitybio Stock Forecast FAQ

Is Immunitybio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: IBRX) stock is to Hold IBRX stock.

Out of 1 analyst, 0 (0%) are recommending IBRX as a Strong Buy, 0 (0%) are recommending IBRX as a Buy, 1 (100%) are recommending IBRX as a Hold, 0 (0%) are recommending IBRX as a Sell, and 0 (0%) are recommending IBRX as a Strong Sell.

If you're new to stock investing, here's how to buy Immunitybio stock.

What is IBRX's revenue growth forecast for 2024-2026?

(NASDAQ: IBRX) Immunitybio's forecast annual revenue growth rate of 574.96% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.57%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.16%.

Immunitybio's revenue in 2024 is $622,000.On average, 1 Wall Street analysts forecast IBRX's revenue for 2024 to be $6,523,858,051, with the lowest IBRX revenue forecast at $6,523,858,051, and the highest IBRX revenue forecast at $6,523,858,051. On average, 1 Wall Street analysts forecast IBRX's revenue for 2025 to be $57,070,278,901, with the lowest IBRX revenue forecast at $57,070,278,901, and the highest IBRX revenue forecast at $57,070,278,901.

In 2026, IBRX is forecast to generate $133,159,491,087 in revenue, with the lowest revenue forecast at $133,159,491,087 and the highest revenue forecast at $133,159,491,087.

What is IBRX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: IBRX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is IBRX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year IBRX price target, the average IBRX price target is $5.00, with the highest IBRX stock price forecast at $5.00 and the lowest IBRX stock price forecast at $5.00.

The Wall Street analyst predicted that Immunitybio's share price could fall to $5.00 by Mar 25, 2025. The average Immunitybio stock price prediction forecasts a potential downside of 8.93% from the current IBRX share price of $5.49.

What is IBRX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: IBRX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.